Rare Disease Day is February 28. Primary sclerosing cholangitis or PSC is a rare liver disease characterized by progressive ...

The phase 1 trial is testing the safety tolerability, pharmacokinetics, and pharmacodynamics of PVT201 in healthy volunteers and patients.

Former NCAA All-American Hockey player and three-time national champion, Julianne Vasichek and Dr. Gideon Hirschfield came by to raise awareness about a rare liver disease. Primary ...

We read with great interest the study by Wunsch et al 1 published in this issue of Polish Archives of Internal Medicine, which validated the prognostic ability of 2 previously ide ...

Objectives Primary sclerosing cholangitis (PSC) is a rare chronic disease that presents challenges to both patients and ...

Wendy Yeh, M.D. Chief Medical Officer, NGM Bio Dr. Yeh will oversee the continued clinical development of NGM Bio’s key ...

Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.

Chemomab is a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need. Based on the unique role of the soluble protein CCL24 in ...

American Liver Foundation (ALF) is thrilled to announce the recipients of its prestigious 2024 Liver Scholar and Postdoctoral Research Fellowship Awards. These awards are part of ALF's continued ...

Medically reviewed by Jay N. Yepuri, MD Primary sclerosing cholangitis (PSC) is a progressive scarring of the liver's bile ...

I'm hearing more about the exposome and the role of the environment on our health. Can you tell me more about how it is being ...

The levels of interferon-gamma (IFN-γ) increases as the disease progresses in patients with primary biliary cholingitis (PBC), a study found.